Announcements Trials

Browse Landscape

Sponsor

Conditions

Pancreatic Neoplasms 58 Carcinoma, Non-Small-Cell Lung 36 Urinary Bladder Neoplasms 33 Neoplasm Metastasis 20 Lung Neoplasms 20 Ovarian Neoplasms 19 Lymphoma, Large B-Cell, Diffuse 18 Cholangiocarcinoma 15 Neoplasms 14 Nasopharyngeal Carcinoma 14 Biliary Tract Neoplasms 14 Triple Negative Breast Neoplasms 13 Colorectal Neoplasms 12 Breast Neoplasms 12 Carcinoma, Transitional Cell 11 Non-Muscle Invasive Bladder Neoplasms 10 Fallopian Tube Neoplasms 10 Recurrence 9 Gallbladder Neoplasms 8 Sarcoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Bile Duct Neoplasms 6 Uterine Cervical Neoplasms 5 Osteosarcoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Hodgkin Disease 5 Endometrial Neoplasms 5 Melanoma 4 Gastrointestinal Neoplasms 4

Interventions

Cisplatin 22 Magnetic Resonance Spectroscopy 15 Specimen Handling 13 Platinum 12 Radiotherapy, Intensity-Modulated 11 1,2-diaminocyclohexaneplatinum II citrate 11 Radiotherapy 10 Radiation 10 Carboplatin 9 Surveys and Questionnaires 5 Biopsy 5 pembrolizumab 4 Taxes 4 Paclitaxel 4 Nivolumab 4 Docetaxel 4 Chemoradiotherapy 4 Cetuximab 4 Observation 3 Fluorodeoxyglucose F18 3 (225)Ac-DOTA-c(RGDyK) 3 durvalumab 2 X-Rays 2 Watchful Waiting 2 Standard of Care 2 Radiotherapy, Image-Guided 2 Interviews as Topic 2 Immunoglobulin G 2 Fluorouracil 2 Disulfides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Oropharyngeal Neoplasms × Gemcitabine × 90 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡